Product image of Metformine Almus (Metformin Hydrochloride) supplied by GNH India

Metformine Almus

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformine Almus (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformine Almus, is a biguanide presented as a standard tablet for oral use. It decreases hepatic glucose production, reduces intestinal glucose absorption, and enhances peripheral insulin sensitivity, helping to lower elevated blood glucose levels in adults with type 2 diabetes mellitus.

GNH India supplies Metformine Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across multiple markets.

Manufacturer / TM Owner

Almus France

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformine Almus (metformin) is employed in the management of disorders related to impaired glucose regulation.

  • Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
  • Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle measures.
  • Polycystic ovary syndrome: reduces insulin resistance and may help restore ovulatory function.

How It Works

  • Metformin inhibits mitochondrial respiratory‑chain complex I, lowering hepatic gluconeogenesis. It activates AMP‑activated protein kinase (AMPK), which enhances peripheral glucose uptake, and reduces intestinal glucose absorption. These combined actions improve insulin sensitivity and decrease circulating blood glucose without directly stimulating insulin secretion.

Side Effects

Metformine Almus may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic acidosis.
  • Severe hypoglycemia: usually when combined with other glucose‑lowering agents.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Skin reactions: rash or Stevens‑Johnson syndrome.
  • Vitamin B12 deficiency: long‑term therapy may reduce absorption.

Precautions & Warnings

Before initiating Metformine Almus, several safety considerations should be reviewed.

  • Renal function: assess creatinine clearance; avoid if severe renal impairment.
  • Hepatic disease: use with caution in patients with liver dysfunction.
  • Cardiovascular status: monitor for heart failure, as metformin is contraindicated in acute decompensation.
  • Concomitant medications: review for drugs that may increase risk of lactic acidosis (e.g., contrast media).
  • Pregnancy and lactation: evaluate risk‑benefit; generally avoided unless clearly needed.
  • Store at ambient temperature: keep below 25°C, protect from moisture in original container.

Avoid Interactions

Metformine Almus can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after imaging.
  • Cimetidine: increases metformin plasma concentrations, raising risk of toxicity.
  • Alcohol excess: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may affect renal function, requiring dose adjustment.
  • Diuretics: can reduce renal clearance of metformin.
  • Beta‑blockers: may mask hypoglycemia symptoms.
  • Sulfonylureas: increase risk of hypoglycemia when combined.
  • Antiretroviral protease inhibitors: may elevate metformin levels.

Frequently Asked Questions

Metformine Almus contains metformin hydrochloride, which is primarily used to improve blood glucose control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes and polycystic ovary syndrome to address insulin resistance.

Metformin works by inhibiting hepatic glucose production, decreasing intestinal absorption of glucose, and increasing peripheral tissue sensitivity to insulin. These actions collectively lower blood sugar levels without stimulating insulin release.

The appropriate dose of Metformine Almus is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety of metformin during pregnancy or lactation is not fully established. The prescriber must weigh potential benefits against risks. In some cases, metformin may be continued if the therapeutic advantage justifies potential exposure, but this decision is made on a case‑by‑case basis.

To order Metformine Almus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformine Almus belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. It does not stimulate insulin secretion, reducing the risk of hypoglycemia, and is often used as first‑line therapy because of its efficacy, weight‑neutral profile, and low cost.

Metformine Almus should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Metformine Almus is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, liver disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformine Almus is contraindicated in patients with severe renal impairment, acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin. It should also be used with caution in individuals with liver disease, heart failure, or a history of alcohol abuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT